It is estimated that 90% of individuals with systemic sclerosis (SSc) have some evidence of pulmonary disease. This makes pulmonary disease second only to esophageal disease as the most common manifestation of SSc.
It is estimated that 90% of individuals with systemic sclerosis (SSc) have some evidence of pulmonary disease. This makes pulmonary disease second only to esophageal disease as the most common manifestation of SSc.
Subscribe and receive a weekly email with important information about scleroderma and the National Scleroderma Foundation